Inhibition of tryptophan-dioxygenase activity increases the antitumor efficacy of immune checkpoint inhibitors

Inhibition of tryptophan-dioxygenase activity increases the antitumor efficacy of immune checkpoint inhibitors

Tryptophan 2,3-dioxygenase (TDO) is an enzyme that degrades tryptophan into kynurenine and thereby induces immunosuppression. Like indoleamine 2,3-dioxygenase (IDO1), TDO is considered as a relevant drug target to improve the efficacy of cancer immunotherapy. However, its role in various immunothera...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Schramme, F, Crosignani, S, Frederix, K, Hoffmann, D, Pilotte, L, Stroobant, V, Preillon, J, Driessens, G, Van Den Eynde, B
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	American Association for Cancer Research 2019

Míreanna comhchosúla

Tryptophan 2,3-dioxygenase expression identified in murine decidual stromal cells is not essential for feto-maternal tolerance
de réir: Hoffmann, D, et al.
Foilsithe / Cruthaithe: (2020)

Tryptophan 2,3-Dioxygenase Expression Identified in Murine Decidual Stromal Cells Is Not Essential for Feto-Maternal Tolerance
de réir: Delia Hoffmann, et al.
Foilsithe / Cruthaithe: (2020-12-01)

Induction of tryptophan 2,3-dioxygenase expression in human monocytic leukemia/lymphoma cell lines THP-1 and U937
de réir: Hoffmann, D, et al.
Foilsithe / Cruthaithe: (2019)

Tryptophanemia is controlled by a tryptophan-sensing mechanism ubiquitinating tryptophan 2,3-dioxygenase
de réir: Klaessens, S, et al.
Foilsithe / Cruthaithe: (2021)

Rational design of original fused-cycle selective inhibitors of tryptophan 2,3-dioxygenase
de réir: Kozlova, A, et al.
Foilsithe / Cruthaithe: (2021)

Investigation of chalcogen bioisosteric replacement in a series of heterocyclic inhibitors of tryptophan 2,3-dioxygenase
de réir: Kozlova, A, et al.
Foilsithe / Cruthaithe: (2021)

Tryptophan 2,3-dioxygenase expression identified in human hepatocellular carcinoma cells and in intratumoral pericytes of most cancers
de réir: Hoffmann, D, et al.
Foilsithe / Cruthaithe: (2019)

Systemic tryptophan homeostasis
de réir: Simon Klaessens, et al.
Foilsithe / Cruthaithe: (2022-09-01)

Systemic tryptophan homeostasis
de réir: Klaessens, S, et al.
Foilsithe / Cruthaithe: (2022)

Rational design of indoleamine 2,3-dioxygenase inhibitors.
de réir: Röhrig, U, et al.
Foilsithe / Cruthaithe: (2010)

Targeting Indoleamine Dioxygenase and Tryptophan Dioxygenase in Cancer Immunotherapy: Clinical Progress and Challenges
de réir: Peng X, et al.
Foilsithe / Cruthaithe: (2022-08-01)

Editorial: Targeting Indoleamine 2,3-dioxygenases and Tryptophan Dioxygenase for Cancer Immunotherapy
de réir: Lieve Brochez, et al.
Foilsithe / Cruthaithe: (2021-12-01)

Tryptophan depletion sensitizes the AHR pathway by increasing AHR expression and GCN2/LAT1-mediated kynurenine uptake, and potentiates induction of regulatory T lymphocytes
de réir: Solvay, M, et al.
Foilsithe / Cruthaithe: (2023)

Negative Impact of Hypoxia on Tryptophan 2,3-Dioxygenase Function
de réir: Frank Elbers, et al.
Foilsithe / Cruthaithe: (2016-01-01)

Unveiling the Role of Tryptophan 2,3-Dioxygenase in the Angiogenic Process
de réir: Marta Cecchi, et al.
Foilsithe / Cruthaithe: (2024-04-01)

Influence of tryptophan contained in 1-Methyl-Tryptophan on antimicrobial and immunoregulatory functions of indoleamine 2,3-dioxygenase.
de réir: Silvia K Schmidt, et al.
Foilsithe / Cruthaithe: (2012-01-01)

Tryptophan depletion sensitizes the AHR pathway by increasing AHR expression and GCN2/LAT1-mediated kynurenine uptake, and potentiates induction of regulatory T lymphocytes
de réir: Luc Pilotte, et al.
Foilsithe / Cruthaithe: (2023-06-01)

Hypoxia Inducible Factor 1α Inhibits the Expression of Immunosuppressive Tryptophan-2,3-Dioxygenase in Glioblastoma
de réir: Soumya R. Mohapatra, et al.
Foilsithe / Cruthaithe: (2019-12-01)

Expression of the kynurenine pathway enzyme tryptophan 2,3-dioxygenase is increased in the frontal cortex of individuals with schizophrenia
de réir: Christine L Miller, et al.
Foilsithe / Cruthaithe: (2004-04-01)

Immunosuppression mediated by enzymes that degrade tryptophan
de réir: Van Den Eynde, B
Foilsithe / Cruthaithe: (2018)

Constitutive IDO1 expression in human tumors is driven by cyclooxygenase-2 and mediates intrinsic immune resistance.
de réir: Hennequart, M, et al.
Foilsithe / Cruthaithe: (2017)

Decreased tryptophan catabolism by placental indoleamine 2,3-dioxygenase in preeclampsia.
de réir: Kudo, Y, et al.
Foilsithe / Cruthaithe: (2003)

Constitutive IDO1 expression in human tumors is driven by cyclooxygenase-2 and mediates intrinsic immune resistance
de réir: Hennequart, M, et al.
Foilsithe / Cruthaithe: (2017)

Significance and Prospect of Tryptophan Metabolism in Treatment of Tumor Immune Checkpoint Inhibitors
de réir: GAO Yamei, et al.
Foilsithe / Cruthaithe: (2021-05-01)

TRYPTOPHAN AND INDOLEAMINE-2,3-DIOXYGENASE (IDO) IN PATHOGENESIS OF IMMUNOSUPPRESSIVE CLINICAL CONDITIONS
de réir: V. A. Kozlov, et al.
Foilsithe / Cruthaithe: (2017-07-01)

Tryptophan-degrading enzymes in tumoral immune resistance
de réir: Nicolas van Baren, et al.
Foilsithe / Cruthaithe: (2016-11-01)

The indoleamine-2,3-dioxygenase (IDO) inhibitor 1-methyl-D-tryptophan upregulates IDO1 in human cancer cells.
de réir: Christiane A Opitz, et al.
Foilsithe / Cruthaithe: (2011-01-01)

Microenvironment tumor metabolic interactions highlighted by qMSI: Application to the tryptophan-kynurenine pathway in immuno-oncology
de réir: Ait-Belkacem, R, et al.
Foilsithe / Cruthaithe: (2017)

Tryptophan degradation by human placental indoleamine 2,3-dioxygenase regulates lymphocyte proliferation.
de réir: Kudo, Y, et al.
Foilsithe / Cruthaithe: (2001)

Comprehensive behavioral analysis of tryptophan 2,3‐dioxygenase (Tdo2) knockout mice
de réir: Satoko Hattori, et al.
Foilsithe / Cruthaithe: (2018-06-01)

The Relationships among Tryptophan, Kynurenine, Indoleamine 2,3-Dioxygenase, Depression, and Neuropsychological Performance
de réir: Knut A. Hestad, et al.
Foilsithe / Cruthaithe: (2017-10-01)

Fully automated radiosynthesis of N1-[18F]fluoroethyl-tryptophan and study of its biological activity as a new potential substrate for indoleamine 2,3-dioxygenase PET imaging
de réir: Henrottin, J, et al.
Foilsithe / Cruthaithe: (2016)

Pleiotropic Effects of Metformin on the Antitumor Efficiency of Immune Checkpoint Inhibitors
de réir: Wenhui Liu, et al.
Foilsithe / Cruthaithe: (2021-02-01)

IDO1 and TDO inhibitory evaluation of analogues of the marine pyrroloiminoquinone alkaloids: Wakayin and Tsitsikammamines
de réir: Levy, T, et al.
Foilsithe / Cruthaithe: (2021)

AHR and tryptophan metabolism: a collaborative dynamics of immune regulation
de réir: Zhu, J, et al.
Foilsithe / Cruthaithe: (2023)

Corrigendum: MicroRNA-153 decreases tryptophan catabolism and inhibits angiogenesis in bladder cancer by targeting indoleamine 2,3-dioxygenase 1
de réir: Wentao Zhang, et al.
Foilsithe / Cruthaithe: (2023-05-01)

Indoleamine 2,3-dioxygenase-Mediated Tryptophan Catabolism Limits Experimental Abdominal Aortic Aneurysms
de réir: Baohui Xu, et al.
Foilsithe / Cruthaithe: (2024-01-01)

Expression of tryptophan 2,3-dioxygenase in mature granule cells of the adult mouse dentate gyrus
de réir: Ohira, Koji, et al.
Foilsithe / Cruthaithe: (2010-09-01)

Activities of plasma indoleamine-2, 3-dioxygenase (IDO) enzyme in Nigerian patients with lung diseases: basis for tryptophan supplementation or IDO inhibitor use
de réir: Ganiyu Olatunbosun Arinola, et al.
Foilsithe / Cruthaithe: (2023-01-01)

Preclinical investigations and a first-in-human phase I trial of M4112, the first dual inhibitor of indoleamine 2,3-dioxygenase 1 and tryptophan 2,3-dioxygenase 2, in patients with advanced solid tumors
de réir: Sen Zhang, et al.
Foilsithe / Cruthaithe: (2020-10-01)